304 related articles for article (PubMed ID: 33130397)
1. RNA binding motif protein 10 suppresses lung cancer progression by controlling alternative splicing of eukaryotic translation initiation factor 4H.
Zhang S; Bao Y; Shen X; Pan Y; Sun Y; Xiao M; Chen K; Wei H; Zuo J; Saffen D; Zong WX; Sun Y; Wang Z; Wang Y
EBioMedicine; 2020 Nov; 61():103067. PubMed ID: 33130397
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis reveals that RBM10 mutations contribute to lung adenocarcinoma pathogenesis by deregulating splicing.
Zhao J; Sun Y; Huang Y; Song F; Huang Z; Bao Y; Zuo J; Saffen D; Shao Z; Liu W; Wang Y
Sci Rep; 2017 Jan; 7():40488. PubMed ID: 28091594
[TBL] [Abstract][Full Text] [Related]
3. RNA-binding motif protein 10 represses tumor progression through the Wnt/β- catenin pathway in lung adenocarcinoma.
Cao Y; Geng J; Wang X; Meng Q; Xu S; Lang Y; Zhou Y; Qi L; Wang Z; Wei Z; Yu Y; Jin S; Pan B
Int J Biol Sci; 2022; 18(1):124-139. PubMed ID: 34975322
[TBL] [Abstract][Full Text] [Related]
4. Key contribution of eIF4H-mediated translational control in tumor promotion.
Vaysse C; Philippe C; Martineau Y; Quelen C; Hieblot C; Renaud C; Nicaise Y; Desquesnes A; Pannese M; Filleron T; Escourrou G; Lawson M; Rintoul RC; Delisle MB; Pyronnet S; Brousset P; Prats H; Touriol C
Oncotarget; 2015 Nov; 6(37):39924-40. PubMed ID: 26498689
[TBL] [Abstract][Full Text] [Related]
5. SAM68 promotes tumorigenesis in lung adenocarcinoma by regulating metabolic conversion via PKM alternative splicing.
Zhu S; Chen W; Wang J; Qi L; Pan H; Feng Z; Tian D
Theranostics; 2021; 11(7):3359-3375. PubMed ID: 33537092
[No Abstract] [Full Text] [Related]
6. RBM10 Loss Promotes EGFR-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition.
Bao Y; Zhang S; Zhang X; Pan Y; Yan Y; Wang N; Ren Y; Zuo J; Zong WX; Wang Z; Wang Y
Cancer Res; 2023 May; 83(9):1490-1502. PubMed ID: 36853175
[TBL] [Abstract][Full Text] [Related]
7. The role of RBM10 mutations in the development, treatment, and prognosis of lung adenocarcinoma.
Li Z; Xue Q; Xu J; Zhang P; Ding B
Cell Cycle; 2020 Nov; 19(21):2918-2926. PubMed ID: 33064970
[TBL] [Abstract][Full Text] [Related]
8. Autoregulation of RBM10 and cross-regulation of RBM10/RBM5 via alternative splicing-coupled nonsense-mediated decay.
Sun Y; Bao Y; Han W; Song F; Shen X; Zhao J; Zuo J; Saffen D; Chen W; Wang Z; You X; Wang Y
Nucleic Acids Res; 2017 Aug; 45(14):8524-8540. PubMed ID: 28586478
[TBL] [Abstract][Full Text] [Related]
9. Tumor suppressor properties of the splicing regulatory factor RBM10.
Hernández J; Bechara E; Schlesinger D; Delgado J; Serrano L; Valcárcel J
RNA Biol; 2016; 13(4):466-72. PubMed ID: 26853560
[TBL] [Abstract][Full Text] [Related]
10. The RNA-binding landscape of RBM10 and its role in alternative splicing regulation in models of mouse early development.
Rodor J; FitzPatrick DR; Eyras E; Cáceres JF
RNA Biol; 2017 Jan; 14(1):45-57. PubMed ID: 27763814
[TBL] [Abstract][Full Text] [Related]
11. Investigation of
Cao Y; Lan D; Ke X; Zheng W; Zeng J; Niu N; Fu C; Deng W; Jin S
Heliyon; 2024 Jun; 10(11):e32287. PubMed ID: 38912481
[TBL] [Abstract][Full Text] [Related]
12. Integrative analysis revealed the molecular mechanism underlying RBM10-mediated splicing regulation.
Wang Y; Gogol-Döring A; Hu H; Fröhler S; Ma Y; Jens M; Maaskola J; Murakawa Y; Quedenau C; Landthaler M; Kalscheuer V; Wieczorek D; Wang Y; Hu Y; Chen W
EMBO Mol Med; 2013 Sep; 5(9):1431-42. PubMed ID: 24000153
[TBL] [Abstract][Full Text] [Related]
13. RBM10 Deficiency Is Associated With Increased Immune Activity in Lung Adenocarcinoma.
Liu B; Wang Y; Wang H; Li Z; Yang L; Yan S; Yang X; Ma Y; Gao X; Guan Y; Yi X; Xia X; Li J; Wu N
Front Oncol; 2021; 11():677826. PubMed ID: 34367963
[TBL] [Abstract][Full Text] [Related]
14. Insight into the role of alternative splicing within the RBM10v1 exon 10 tandem donor site.
Tessier SJ; Loiselle JJ; McBain A; Pullen C; Koenderink BW; Roy JG; Sutherland LC
BMC Res Notes; 2015 Feb; 8():46. PubMed ID: 25889998
[TBL] [Abstract][Full Text] [Related]
15. miR-335 modulates Numb alternative splicing via targeting RBM10 in endometrial cancer.
Dou XQ; Chen XJ; Zhou Q; Wen MX; Zhang SZ; Zhang SQ
Kaohsiung J Med Sci; 2020 Mar; 36(3):171-177. PubMed ID: 31894898
[TBL] [Abstract][Full Text] [Related]
16. RNA-binding motif protein 10 inactivates c-Myc by partnering with ribosomal proteins uL18 and uL5.
Lee H; Jung JH; Ko HM; Park H; Segall AM; Sheffmaker RL; Wang J; Frey WD; Pham N; Wang Y; Zhang Y; Jackson JG; Zeng SX; Lu H
Proc Natl Acad Sci U S A; 2023 Dec; 120(49):e2308292120. PubMed ID: 38032932
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of miR-519d in lung adenocarcinoma inhibits cell proliferation and invasion via the association of eIF4H.
Bai Y; Lu C; Zhang G; Hou Y; Guo Y; Zhou H; Ma X; Zhao G
Tumour Biol; 2017 Mar; 39(3):1010428317694566. PubMed ID: 28351305
[TBL] [Abstract][Full Text] [Related]
18. An alternative splicing isoform of eukaryotic initiation factor 4H promotes tumorigenesis in vivo and is a potential therapeutic target for human cancer.
Wu D; Matsushita K; Matsubara H; Nomura F; Tomonaga T
Int J Cancer; 2011 Mar; 128(5):1018-30. PubMed ID: 20473909
[TBL] [Abstract][Full Text] [Related]
19. RBM10 inhibits cell proliferation of lung adenocarcinoma via RAP1/AKT/CREB signalling pathway.
Jin X; Di X; Wang R; Ma H; Tian C; Zhao M; Cong S; Liu J; Li R; Wang K
J Cell Mol Med; 2019 Jun; 23(6):3897-3904. PubMed ID: 30955253
[TBL] [Abstract][Full Text] [Related]
20. A novel circular RNA, circXPO1, promotes lung adenocarcinoma progression by interacting with IGF2BP1.
Huang Q; Guo H; Wang S; Ma Y; Chen H; Li H; Li J; Li X; Yang F; Qiu M; Zhao S; Wang J
Cell Death Dis; 2020 Dec; 11(12):1031. PubMed ID: 33268793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
